Identity
Confirm the stated molecule and supplied form. Start with the matching batch COA; request sequence-level evidence only when the buyer's written procedure requires it and availability or a separate scope has been agreed.
Quality system
Specify the evidence before you specify the claim.
A research peptide can meet a purity target and still fail an identity or content question. LyoPep structures qualification around the supplied form, the intended research workflow and a released batch.
Qualification matrix
Identity, purity and content are separate release questions.
Purity
Review RP-HPLC method conditions, wavelength, integration and related-peak handling. A percentage without the method is not enough.
Content
Net peptide content is not the same as gross lyophilized powder weight. Ask which assay supports the stated amount and whether water/counter-ion is addressed.
Stability
Define long-term storage and transit exposure separately. Cold-chain can be quoted when the buyer’s risk assessment requires it and adds cost.
Batch and third-party evidence
Batch COAs and third-party test reports for popular products.
Compare representative LyoPep batch release records with corresponding third-party test reports. These thumbnails provide document-review context and do not replace the current-lot analytical packet.
01
Popular product
50 mgRetatrutide
02
Popular product
10 mgBPC-157
03
Popular product
10 mgBPC-157 + TB-500
04
Popular product
10 mgTB-500
05
Popular product
10 mgMOTS-c
06
Popular product
10 mgCJC-1295 + Ipamorelin
07
Popular product
50 mgEpithalon
08
Popular product
10 mgThymosin Alpha-1
09
Popular product
50 mgSS-31
Need the complete analytical documents?
For complete and detailed COAs, submit an inquiry and contact a sales representative to confirm the current lot, available test data and document scope.
Third-party reports are representative test records, not a claim of accreditation, legal certification or applicability to every lot.Batch release workflow
One controlled handoff from requirement to dispatch.
Released-batch COA
Each product inquiry can request the latest available COA for the lot being offered.
Pre-agreed independent testing
A mutually accepted specialist laboratory may be commissioned under an agreed method, fee allocation and acceptance rule. Unless otherwise agreed in writing, the buyer pays the cost of this optional testing.
Documented remedy
Confirmed nonconformance is handled under the signed order terms, which may include replacement, credit or refund.
Buyer FAQ
Terms to settle before the purchase order
Can a buyer arrange third-party testing?+
Yes. Testing must be performed by a mutually accepted, established specialist laboratory. Fee allocation, specification, sampling, method and acceptance rule must be agreed before testing; if an agreed independent result shows nonconformance, the remedy follows the signed order terms. Unless otherwise agreed in writing, the buyer pays the cost of this optional testing.
Does HPLC purity prove peptide content?+
No. Chromatographic purity describes the relative peak profile under a stated method. Identity, water, counter-ion, residual solvents and assay/content may require separate methods.
Is cold-chain shipping always required?+
Not always. Heat can accelerate degradation, especially during summer and long transit. Cold-chain reduces exposure but raises cost. State the destination and stability risk so the right service can be quoted.
How are payment terms handled?+
Available methods and milestones depend on order value, destination and project type. The pro forma invoice should state currency, bank details, fees, payment milestones and the release condition.
Why must the testing laboratory understand peptide chemistry?+
Free-base and salt forms, hydrophilic and hydrophobic sequences, aggregation and adsorption can change sample preparation and method suitability. Use a laboratory experienced with the molecule class.
Materials still needed before production launch
Current pages avoid unverified certification and capacity claims. Provide valid certificates, anonymized released-batch COA examples, method SOP summaries, stability or shipping validation, facility legal identity and third-party lab agreements before those claims are promoted.